Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Other-Current-Liabilities" stands at 16.32 Billion United States Dollars as of 09/30/2025.
As of the end of Novartis AG's third quarter, the item "Other Current Liabilities" stands at 16.32 Billion USD. This represents an increase of 3.23 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 8.31 percent compared to the value the year prior.
The 1 year change in percent is 8.31.
The 3 year change in percent is 21.11.
The 5 year change in percent is 13.13.
The 10 year change in percent is 16.20.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Current Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Current Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Current Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Current Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Current Liabilities | 280,205,508,085.11 |